Page last updated: 2024-08-17

perflutren and su 11248

perflutren has been researched along with su 11248 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Atri, M; Bjarnason, GA; Burns, PN; Hudson, JM; Lloyd, BA; Lueck, G; Milot, L; Sureshkumar, AR; Williams, R1
Atri, M; Bjarnason, GA; Burns, PN; Hudson, JM; Karshafian, R; Milot, L; Williams, R1

Reviews

1 review(s) available for perflutren and su 11248

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for perflutren and su 11248

ArticleYear
Quantifying vascular heterogeneity using microbubble disruption-replenishment kinetics in patients with renal cell cancer.
    Investigative radiology, 2014, Volume: 49, Issue:2

    Topics: Adult; Aged; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Contrast Media; Female; Fluorocarbons; Humans; Image Interpretation, Computer-Assisted; Indoles; Kidney Neoplasms; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Sunitinib; Ultrasonography

2014

Other Studies

1 other study(ies) available for perflutren and su 11248

ArticleYear
Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy.
    Radiology, 2011, Volume: 260, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Area Under Curve; Carcinoma, Renal Cell; Contrast Media; Evidence-Based Medicine; Female; Fluorocarbons; Humans; Indoles; Kidney Neoplasms; Male; Microbubbles; Middle Aged; Neoplasm Metastasis; Pyrroles; Reproducibility of Results; Statistics, Nonparametric; Sunitinib; Survival Analysis; Tomography, X-Ray Computed; Ultrasonography

2011